Global Computer Aided Detection (CAD) Market, By Application (Breast Cancer, Lung Cancer, Colon/Rectal Cancer, Prostate Cancer, Liver Cancer, Bone Cancer, and Neurological/ Musculoskeletal/ Cardiovascular Cancer), Breast CAD Imaging Modalities (Mammography, Magnetic Resonance Imaging, Ultrasound Imaging, Tomosynthesis, and Nuclear Imaging), Imaging Modalities (X-Ray Imaging, Computed Tomography, Ultrasound Imaging, Magnetic Resonance, and Nuclear Medicine Imaging), End User (Hospitals, Diagnostic Centers and Research Centers) – Industry Trends and Forecast to 2031.
Computer Aided Detection (CAD) Market Analysis and Size
The global computer-aided detection (CAD) market is experiencing significant growth, driven by the increasing prevalence of chronic diseases such as cancer and the growing adoption of advanced imaging modalities. CAD systems play a crucial role in enhancing the accuracy and efficiency of disease detection by assisting radiologists and healthcare professionals in interpreting medical images. The market is also being propelled by technological advancements in CAD software, such as the integration of artificial intelligence (AI) and machine learning algorithms, which enable more precise and automated analysis of medical images. In addition, the rising demand for early and accurate diagnosis, coupled with the increasing awareness about the benefits of CAD systems, is fueling market growth.
Global computer aided detection (CAD) market size was valued at USD 896.26 million in 2023 and is projected to reach USD 1852.45 million by 2031, with a CAGR of 9.5% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Application (Breast Cancer, Lung Cancer, Colon/Rectal Cancer, Prostate Cancer, Liver Cancer, Bone Cancer, and Neurological/Musculoskeletal/Cardiovascular Cancer), Breast CAD Imaging Modalities (Mammography, Magnetic Resonance Imaging, Ultrasound Imaging, Tomosynthesis, and Nuclear Imaging), Imaging Modalities (X-Ray Imaging, Computed Tomography, Ultrasound Imaging, Magnetic Resonance, and Nuclear Medicine Imaging), End User (Hospitals, Diagnostic Centers and Research Centers)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, Rest of South America
|
|
Market Players Covered
|
EDDA Technology, Inc. (U.S.), FUJIFILM Holdings Corporation (Japan), Hologic, Inc. (U.S.), iCAD Inc. (U.S.), Koninklijke Philips N.V. (Netherlands), Siemens (Germany), CANON MEDICAL SYSTEMS CORPORATION (Japan), IBM (U.S.), Riverain Technologies (U.S.), Median Technologies (France), GENERAL ELECTRIC (U.S.), Shimadzu Analytical (India), Pvt. Ltd. (India), Carestream Health (U.S.), Hitachi Ltd. (Japan), ESAOTE SPA (Italy), Narayana Hrudayalaya Ltd (India), Karyopharm (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Computer-aided detection (CAD) is a technology used in medical imaging that assists radiologists and other healthcare professionals in interpreting medical images, such as X-rays, MRIs, and CT scans. CAD systems use algorithms to highlight suspicious areas or abnormalities in the images, which can help healthcare providers detect potential signs of disease, such as cancer, more accurately and efficiently.
Computer Aided Detection (CAD) Market Dynamics
Drivers
- Increasing Prevalence of Chronic Diseases
CAD systems play a crucial role in the early detection and diagnosis of these diseases, leading to better patient outcomes. As the global population ages and lifestyles become more sedentary, the prevalence of chronic diseases is expected to increase, driving the demand for CAD systems. These systems help healthcare providers detect abnormalities in medical images, enabling early intervention and improving treatment outcomes for patients. The rising incidence of chronic diseases, such as cancer and cardiovascular disorders, is a key driver for the computer aided detection market.
- Technological Advancements in Imaging Modalities
Technological advancements in imaging modalities, such as MRI, CT, and mammography,have led to higher-resolution imaging, which requires more sophisticated analysis tools provided by CAD. For example, CAD systems can analyze mammograms to detect early signs of breast cancer that may not be visible to the naked eye. As imaging technology continues to evolve, the demand for CAD systems is expected to increase, driving market growth.
Opportunities
- Focus on Telemedicine and Remote Imaging
Developing CAD systems tailored for telemedicine applications can expand market reach and improve access to healthcare in remote areas. CAD systems can enable healthcare providers to analyze medical images remotely, allowing for more efficient diagnosis and treatment planning. In addition, telemedicine can reduce the need for patients to travel long distances for medical consultations, improving patient convenience and reducing healthcare costs. The increasing adoption of telemedicine and remote imaging technologies presents opportunities for CAD manufacturers.
- Investment in Research and Development
Developing more advanced imaging technologies and analysis algorithms can enhance the performance of CAD systems and drive market growth. For example, researchers are exploring the use of AI and machine learning algorithms to improve the accuracy and efficiency of CAD systems. By investing in R&D, CAD manufacturers can stay ahead of the competition and meet the evolving needs of healthcare providers and patients. Continued investment in research and development (R&D) can drive innovation in CAD systems.
Restraints/Challenges
- High Cost of CAD Systems
The high cost of CAD systems is a significant barrier to adoption, particularly in developing regions where healthcare budgets are limited. The initial investment required for CAD systems, including the purchase of equipment, software, and training, can be prohibitive for some healthcare providers. Additionally, ongoing maintenance costs and the need for regular upgrades further contribute to the overall cost of CAD implementation. As a result, many healthcare facilities in developing regions may opt to forego computer aided detection systems or delay their adoption, limiting access to advanced diagnostic tools for patients in these areas.
- Limited Reimbursement Policies
Limited reimbursement policies for CAD procedures can hinder market growth by reducing the financial incentives for healthcare providers to invest in CAD systems. In many healthcare systems, reimbursement for CAD procedures may not adequately cover the cost of the technology, leading to financial losses for providers. As a result, healthcare facilities may be reluctant to invest in CAD systems or may limit their use to only those cases where reimbursement is guaranteed. This limited reimbursement can also deter manufacturers from developing new CAD technologies or expanding their market reach, further impeding market growth.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In March 2022, EDDA Technology signed an agreement with the Society of Interventional Oncology (SIO) for the Ablation with Confirmation of Colorectal Liver Metastases Prospective Trial for Microwave Ablation as a Local Cure (ACCLAIM)
- In November 2021, Fujifilm announced clinical trials for the REiLI Artificial Intelligence Platform, designed for the detection and diagnosis of intracranial hemorrhage and breast cancer
Computer Aided Detection (CAD) Market Scope
The computer aided detection (CAD) market is segmented on the basis of application, breast CAD imaging modalities, imaging modalities, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Application
- Breast Cancer
- Lung Cancer
- Colon/Rectal Cancer
- Prostate Cancer
- Liver cancer
- Bone Cancer
- Neurological/Musculoskeletal/Cardiovascular Cancer
Breast CAD Imaging Modalities
- Mammography
- Magnetic Resonance Imaging
- Ultrasound Imaging
- Tomosynthesis
- Nuclear Imaging
Imaging Modalities
- X-Ray Imaging
- Computed Tomography
- Ultrasound Imaging
- Magnetic Resonance
- Nuclear Medicine Imaging
End User
- Hospitals
- Diagnostic Centres
- Research Centres
Computer Aided Detection (CAD) Market Regional Analysis/Insights
The market is analyzed and market size insights and trends are provided by country, application, breast CAD imaging modalities, imaging modalities, and end user as referenced above.
The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.
North America is expected to dominate the market due to the region's increasing healthcare expenditure, which drives overall healthcare growth. The higher adoption of CAD for the diagnosis of cancer within North America contributes to its leading position in the market. The region's advanced healthcare infrastructure and strong emphasis on technological innovation further bolster the adoption of CAD systems.
Asia-Pacific is expected to witness significant growth during the forecast period due to increasing awareness among patients regarding the importance of early detection of chronic diseases, coupled with promotional campaigns that emphasize the benefits of CAD systems in early diagnosis. The region's growing healthcare infrastructure and rising disposable incomes also play a key role in driving the adoption of CAD systems in Asia-Pacific.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.
Competitive Landscape and Computer Aided Detection (CAD) Market Share Analysis
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Some of the major players operating in the market are:
- EDDA Technology, Inc. (U.S.)
- FUJIFILM Holdings Corporation (Japan)
- Hologic, Inc. (U.S.)
- iCAD Inc. (U.S.)
- Koninklijke Philips N.V. (Netherlands)
- Siemens (Germany)
- CANON MEDICAL SYSTEMS CORPORATION (Japan)
- IBM (U.S.)
- Riverain Technologies (U.S.)
- Median Technologies (France)
- GENERAL ELECTRIC (U.S.)
- Shimadzu Analytical (India) Pvt. Ltd. (India)
- Carestream Health (U.S.)
- Hitachi Ltd. (Japan)
- ESAOTE SPA (Italy)
- Narayana Hrudayalaya Ltd (India)
- Karyopharm (U.S.)
SKU-